arXiv subjects

Petros Liakopoulos

Publications and source records attributed to Petros Liakopoulos.

3 recordsLinked to original sources

arXiv2025

AI-powered virtual tissues from spatial proteomics for clinical diagnostics and biomedical discovery

Spatial proteomics technologies have transformed our understanding of complex tissue architecture in cancer but present unique challenges for computational analysis. Each study uses a different marker panel and protocol, and most methods are tailored to single cohorts, which limits knowledge transfer and robust biomarker discovery. Here we present Virtual Tissues (VirTues), a general-purpose foundation model for spatial proteomics that learns marker-aware, multi-scale representations of proteins, cells, niches and tissues directly from multiplex imaging data. From a single pretrained backbone, VirTues supports marker reconstruction, cell typing and niche annotation, spatial biomarker discovery, and patient stratification, including zero-shot annotation across heterogeneous panels and datasets. In triple-negative breast cancer, VirTues-derived biomarkers predict anti-PD-L1 chemo-immunotherapy response and stratify disease-free survival in an independent cohort, outperforming state-of-the-art biomarkers derived from the same datasets and current clinical stratification schemes.

q-bio.QM↗

arXiv2025

MTBBench: A Multimodal Sequential Clinical Decision-Making Benchmark in Oncology

Multimodal Large Language Models (LLMs) hold promise for biomedical reasoning, but current benchmarks fail to capture the complexity of real-world clinical workflows. Existing evaluations primarily assess unimodal, decontextualized question-answering, overlooking multi-agent decision-making environments such as Molecular Tumor Boards (MTBs). MTBs bring together diverse experts in oncology, where diagnostic and prognostic tasks require integrating heterogeneous data and evolving insights over time. Current benchmarks lack this longitudinal and multimodal complexity. We introduce MTBBench, an agentic benchmark simulating MTB-style decision-making through clinically challenging, multimodal, and longitudinal oncology questions. Ground truth annotations are validated by clinicians via a co-developed app, ensuring clinical relevance. We benchmark multiple open and closed-source LLMs and show that, even at scale, they lack reliability -- frequently hallucinating, struggling with reasoning from time-resolved data, and failing to reconcile conflicting evidence or different modalities. To address these limitations, MTBBench goes beyond benchmarking by providing an agentic framework with foundation model-based tools that enhance multi-modal and longitudinal reasoning, leading to task-level performance gains of up to 9.0% and 11.2%, respectively. Overall, MTBBench offers a challenging and realistic testbed for advancing multimodal LLM reasoning, reliability, and tool-use with a focus on MTB environments in precision oncology.

cs.LG↗

arXiv2024

HoverFast: an accurate, high-throughput, clinically deployable nuclear segmentation tool for brightfield digital pathology images

In computational digital pathology, accurate nuclear segmentation of Hematoxylin and Eosin (H&E) stained whole slide images (WSIs) is a critical step for many analyses and tissue characterizations. One popular deep learning-based nuclear segmentation approach, HoverNet, offers remarkably accurate results but lacks the high-throughput performance needed for clinical deployment in resource-constrained settings. Our approach, HoverFast, aims to provide fast and accurate nuclear segmentation in H&E images using knowledge distillation from HoverNet. By redesigning the tool with software engineering best practices, HoverFast introduces advanced parallel processing capabilities, efficient data handling, and optimized postprocessing. These improvements facilitate scalable high-throughput performance, making HoverFast more suitable for real-time analysis and application in resource-limited environments. Using a consumer grade Nvidia A5000 GPU, HoverFast showed a 21x speed improvement as compared to HoverNet; reducing mean analysis time for 40x WSIs from ~2 hours to 6 minutes while retaining a concordant mean Dice score of 0.91 against the original HoverNet output. Peak memory usage was also reduced 71% from 44.4GB, to 12.8GB, without requiring SSD-based caching. To ease adoption in research and clinical contexts, HoverFast aligns with best-practices in terms of (a) installation, and (b) containerization, while (c) providing outputs compatible with existing popular open-source image viewing tools such as QuPath. HoverFast has been made open-source and is available at andrewjanowczyk.com/open-source-tools/hoverfast.

q-bio.QM↗